TREAT (Telemedicine for Reach, Education, Access, and Treatment)
| Status: | Completed |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/11/2015 |
| Start Date: | May 2011 |
| End Date: | December 2013 |
| Contact: | Donna Tarleton, RN |
| Email: | tarletond@upmc.edu |
| Phone: | 814 676 7994 |
The purpose of this study is to evaluate the feasibility and clinical efficacy of an
innovative care model that combines Telemedicine consultations, educator therapeutic
management and diabetes education to empower patients to be in greater control of their own
diabetes care for improvements in diabetes outcomes.
innovative care model that combines Telemedicine consultations, educator therapeutic
management and diabetes education to empower patients to be in greater control of their own
diabetes care for improvements in diabetes outcomes.
This study will assess whether a new care delivery model combining telemedicine
videoconference diabetes consultations with diabetes self-management teaching is efficacious
in reducing HbA1c in patients with type 2 diabetes in rural areas. The control group will
consist of patients with type 2 diabetes receiving "usual care", i.e., who have not
received a referral to the endocrinologist telemedicine team. Secondary outcomes include
patient satisfaction, level of understanding of self-management skills, and hypoglycemia
videoconference diabetes consultations with diabetes self-management teaching is efficacious
in reducing HbA1c in patients with type 2 diabetes in rural areas. The control group will
consist of patients with type 2 diabetes receiving "usual care", i.e., who have not
received a referral to the endocrinologist telemedicine team. Secondary outcomes include
patient satisfaction, level of understanding of self-management skills, and hypoglycemia
Inclusion Criteria:
- Age 18 or older with type 2 diabetes
- Referral by a primary care provider.
- HbA1c equal or greater than 7.0%.
Exclusion Criteria:
- Type 1 diabetes
- Gestational Diabetes
We found this trial at
1
site
Click here to add this to my saved trials
